Aurinia Pharmaceuticals Inc (AUPH)
5.52
-0.05
(-0.90%)
USD |
NASDAQ |
Jun 26, 11:25
Aurinia Pharmaceuticals Revenue (Annual): 175.51M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 175.51M |
| December 31, 2022 | 134.03M |
| December 31, 2021 | 45.60M |
| December 31, 2020 | 50.12M |
| December 31, 2019 | 0.318M |
| December 31, 2018 | 0.463M |
| December 31, 2017 | 0.418M |
| December 31, 2016 | 0.173M |
| December 31, 2015 | 0.235M |
| December 31, 2014 | 0.278M |
| December 31, 2013 | 0.969M |
| December 31, 2012 | 6.158M |
| December 31, 2011 | 0.9275M |
| Date | Value |
|---|---|
| December 31, 2010 | 3.420M |
| December 31, 2009 | 2.544M |
| December 31, 2008 | 3.877M |
| December 31, 2007 | 2.335M |
| December 31, 2006 | 3.523M |
| December 31, 2005 | 1.178M |
| December 31, 2004 | 1.274M |
| December 31, 2003 | 7.661M |
| December 31, 2002 | 11.92M |
| December 31, 2001 | 5.297M |
| November 30, 2000 | 0.9028M |
| November 30, 1999 | 1.290M |
| November 30, 1998 | 1.237M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.318M
Minimum
2019
175.51M
Maximum
2023
81.12M
Average
50.12M
Median
2020